0 Chikungunya vaccine to enter Phase II trials in endemic areas
A chikungunya vaccine, developed by Themis Bioscience GmbH will be assessed for safety and efficacy in Phase II trials in Puerto Rico from August 2017.
Browsing: Emerging Disease > Chikungunya
0 Harnessing citizen science to tackle mosquito-borne diseases
Human mobility and globalization have brought new invasive species to other countries. In terms of environment and nature, some of…
0 Could severe complications from Zika infection be more common than previously thought?
Researchers have analyzed the clinical characteristics of Zika infection in Canadian travelers returning from the Americas, discovering that severe complications might be more common than previously estimated.
0 New study elucidates a key infection mechanism for chikungunya virus
Researchers have identified a crucial mechanism by which the chikungunya virus infects host cells and mediates disease severity. This could present a future treatment target for both chikungunya and related viruses.
0 Vaccines against chikungunya, Zika and other emerging Aedes mosquito-borne viruses: unblocking existing bottlenecks
In this review the author looks at the progress of vaccine development towards mosquito-borne viral diseases, such as Zika and chikungunya.